Autor segons l'article: Pavel MC; Casanova R; Estalella L; Memba R; Llàcer-Millán E; Achalandabaso M; Julià E; Geoghegan J; Jorba R
Departament: Medicina i Cirurgia
Autor/s de la URV: Estalella Mercadé, Laia / Jorba Martin, Rosa Maria / Llàcer Millán, Erik / Memba Ikuga, Roberto
Paraules clau: Systematic review Portal vein embolization Neoadjuvant chemotherapy Liver resection Liver regeneration Endothelial growth-factor Colorectal cancer liver metastasis systematic review surgery steatohepatitis portal vein embolization oxaliplatin neoadjuvant chemotherapy liver resection irinotecan insufficiency colorectal cancer liver metastasis cancer bevacizumab 2-stage hepatectomy
Resum: © 2020, The Author(s). Introduction: Liver resection (LR) in patients with liver metastasis from colorectal cancer remains the only curative treatment. Perioperative chemotherapy improves prognosis of these patients. However, there are concerns regarding the effect of preoperative chemotherapy on liver regeneration, which is a key event in avoiding liver failure after LR. The primary objective of this systematic review is to assess the effect of neoadjuvant chemotherapy on liver regeneration after (LR) or portal vein embolization (PVE) in patients with liver metastasis from colorectal cancer. The secondary objectives are to evaluate the impact of the type of chemotherapy, number of cycles, and time between end of treatment and procedure (LR or PVE) and to investigate whether there is an association between degree of hypertrophy and postoperative liver failure. Methods: This meta-analysis will include studies reporting liver regeneration rates in patients submitted to LR or PVE. Pubmed, Scopus, Web of Science, Embase, and Cochrane databases will be searched. Only studies comparing neoadjuvant vs no chemotherapy, or comparing chemotherapy characteristics (bevacizumab administration, number of cycles, and time from finishing chemotherapy until intervention), will be included. We will select studies from 1990 to present. Two researchers will individually screen the identified records, according to a list of inclusion and exclusion criteria. Primary outcome will be future liver remnant regeneration rate. Bias of the studies will be evaluated with the ROBINS-I tool, and quality of evidence for all outcomes will be determined with the GRADE system. The data will be registered in a predesigned database. If selected studies are sufficiently homogeneous, we will perform a meta-analysis of reported results. In the event of a substantial heterogeneity, a qualitative systematic review will be performed. Discussion: The results of this systematic review may help to better identify the patients affected by liver metastasis that could present low regeneration rates after neoadjuvant chemotherapy. These patients are at risk to develop liver failure after extended hepatectomies and therefore are not good candidates for such aggressive procedures. Systematic review registration: PROSPERO registration number: CRD42020178481 (July 5, 2020).
Àrees temàtiques: Saúde coletiva Odontología Medicine, general & internal Medicine (miscellaneous) Medicina iii Medicina ii Medicina i Interdisciplinar Farmacia Enfermagem Educação física Ciências biológicas iii
Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
Adreça de correu electrònic de l'autor: roberto.memba@urv.cat roberto.memba@urv.cat erik.llacer@urv.cat rosamaria.jorba@urv.cat
Identificador de l'autor: 0000-0003-3307-4340
Data d'alta del registre: 2024-09-21
Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
Enllaç font original: https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-020-01545-w
URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
Referència a l'article segons font original: Systematic Reviews. 9 (1): 279-
Referència de l'ítem segons les normes APA: Pavel MC; Casanova R; Estalella L; Memba R; Llàcer-Millán E; Achalandabaso M; Julià E; Geoghegan J; Jorba R (2020). The effect of preoperative chemotherapy on liver regeneration after portal vein embolization/ligation or liver resection in patients with colorectal liver metastasis: a systematic review protocol. Systematic Reviews, 9(1), 279-. DOI: 10.1186/s13643-020-01545-w
DOI de l'article: 10.1186/s13643-020-01545-w
Entitat: Universitat Rovira i Virgili
Any de publicació de la revista: 2020
Tipus de publicació: Journal Publications
Repositori URV